EVEROLIMUS - ANVISA Registration 10287411264
Access comprehensive regulatory information for EVEROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411264 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Sep 11, 2027.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS, INC., MICROGENICS CORPORATION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10287411264
25351330594201792
30280358000186
Company Information
Dates and Status
Sep 11, 2017
11/09/2027
09/18/2025 19:00:01
EVEROLIMUS
Família QMS Everolimus
MICROGENICS CORPORATION
80254180465
Mar 25, 2024
EVEROLIMUS
Família QMS Everolimus
Not specified
80254180465
Mar 25, 2024
EVEROLIMUS
Família Dimension Everolimus (EVRO)
Not specified
10345162463
Mar 20, 2023
EVEROLIMUS
Família Dimension Everolimus (EVRO)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
10345162463
Mar 20, 2023
EVEROLIMUS
Família Elecsys Everolimus
Not specified
10287411167
Oct 24, 2016

